---
document_datetime: 2025-11-27 11:36:35
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/rubraca-epar-all-authorised-presentations_en.pdf
document_name: rubraca-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0666372
conversion_datetime: 2025-12-20 16:27:05.823165
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number                                                                       | (Invented) name                 | Strength                           | Pharmaceutical Form                                                         | Route of Administration                      | Immediate Packaging                                                   | Pack size            |
|--------------------------------------------------------------------------------------|---------------------------------|------------------------------------|-----------------------------------------------------------------------------|----------------------------------------------|-----------------------------------------------------------------------|----------------------|
| EU/1/17/1250/001 EU/1/17/1250/002 EU/1/17/1250/003 EU/1/17/1250/004 EU/1/17/1250/005 | Rubraca Rubraca Rubraca Rubraca | 200 mg 250 mg 300 mg 200 mg 250 mg | Film-coated tablet Film-coated tablet Film-coated tablet Film-coated tablet | Oral use Oral use Oral use Oral use Oral use | bottle (HDPE) bottle (HDPE) bottle (HDPE) bottle (HDPE) bottle (HDPE) | 60 tablets           |
|                                                                                      |                                 |                                    |                                                                             |                                              |                                                                       | 60 tablets           |
|                                                                                      |                                 |                                    |                                                                             |                                              |                                                                       | 60 tablets           |
|                                                                                      |                                 |                                    |                                                                             |                                              |                                                                       | 120 (2 x 60) tablets |
|                                                                                      | Rubraca                         |                                    | Film-coated tablet                                                          |                                              |                                                                       | 120 (2 x 60) tablets |
| EU/1/17/1250/006                                                                     | Rubraca                         | 300 mg                             | Film-coated tablet                                                          | Oral use                                     | bottle (HDPE)                                                         | 120 (2 x 60) tablets |